Abstract
Disturbed calcium (Ca2+) homeostasis, which is implicit to the aging phenotype of klotho-deficient mice, has been attributed to altered vitamin D metabolism, but alternative possibilities exist. We hypothesized that failed tubular Ca2+ absorption is primary, which causes increased urinary Ca2+ excretion, leading to elevated 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] and its sequelae. Here, we assessed intestinal Ca2+ absorption, bone densitometry, renal Ca2+ excretion, and renal morphology via energy-dispersive x-ray microanalysis in wild-type and klotho−/− mice. We observed elevated serum Ca2+ and fractional excretion of Ca2+ (FECa) in klotho−/− mice. Klotho−/− mice also showed intestinal Ca2+ hyperabsorption, osteopenia, and renal precipitation of calcium-phosphate. Duodenal mRNA levels of transient receptor potential vanilloid 6 (TRPV6) and calbindin-D9K increased. In the kidney, klotho−/− mice exhibited increased expression of TRPV5 and decreased expression of the sodium/calcium exchanger (NCX1) and calbindin-D28K, implying a failure to absorb Ca2+ through the distal convoluted tubule/connecting tubule (DCT/CNT) via TRPV5. Gene and protein expression of the vitamin D receptor (VDR), 25-hydroxyvitamin D-1-α-hydroxylase (1αOHase), and calbindin-D9K excluded renal vitamin D resistance. By modulating the diet, we showed that the renal Ca2+ wasting was not secondary to hypercalcemia and/or hypervitaminosis D. In summary, these findings illustrate a primary defect in tubular Ca2+ handling that contributes to the precipitation of calcium-phosphate in DCT/CNT. This highlights the importance of klotho to the prevention of renal Ca2+ loss, secondary hypervitaminosis D, osteopenia, and nephrocalcinosis.
Characterization of a mouse that showed a phenotype comparable to human aging led to the identification of the hormone klotho.1 Klotho−/− mice have atherosclerosis, osteopenia, soft tissue calcifications, pulmonary emphysema, and altered glucose metabolism.1 It has been suggested that the etiology of many of these findings is a primary defect in phosphorous [P(i)] and calcium (Ca2+) homeostasis.2,3 Klotho−/− mice have elevated serum levels of Ca2+.1,4,5 The mechanism mediating hypercalcemia is poorly understood. A possible explanation invokes the role of klotho in vitamin D homeostasis. Klotho has been proposed to participate in a negative feedback circuit to inhibit 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] synthesis.6,7 Specifically, klotho is necessary to transduce the signal of fibroblast growth factor 23 (FGF23) through the FGF receptor, thereby suppressing CYP1b expression, the enzyme that mediates the conversion of 25-hydroxyvitamin D into 1,25(OH)2D3. Thus, the absence of klotho results in increased serum levels of 1,25(OH)2D3 and reduced serum concentrations of the calciotropic hormone parathyroid hormone.4,7,8 This would drive increased resorption of Ca2+ from bone, hyperabsorption from the intestine, increased serum levels of Ca2+, and consequently increase renal Ca2+ excretion. Definitive proof of this is lacking because the molecular control of Ca2+ homeostasis in klotho−/− mice has yet to be delineated.
Consistent with the above hypothesis is the observation that klotho−/− mice display hypercalciuria4,5,9 and that normalization of serum 1,25(OH)2D3 levels reverts many, but not all, of their abnormalities.6 The published literature supports an alternative, complementary hypothesis.9–11 A primary defect in tubular Ca2+ handling might cause hypervitaminosis D and renal Ca2+ wasting observed in klotho−/− mice. Consistent with this idea, in vitro, klotho mediates an increase in cell surface expression of transient receptor potential vanilloid 5 (TRPV5)10,11 the distal convoluted tubule/connecting tubule (DCT/CNT) channel responsible for the transcellular absorption of Ca2+.12 This process is itself implicit to Ca2+ homeostasis as TRPV5 is the predominant regulator of urinary Ca2+ excretion.13 Therefore, we set out to test the hypothesis that klotho−/− mice have a primary renal Ca2+ leak that contributes to a secondary increase in 1,25(OH)2D3 synthesis and its consequences.
Results
Klotho−/− Mice Show Hypercalcemia and Hypercalciuria
Klotho−/− mice between the age of 7 and 8 wk were housed for 24 h in metabolic cages, after which they were killed, serum was collected, and kidney, intestine, and bone were isolated. Klotho−/− mice display significant hypercalcemia and hyperphosphatemia (Figure 1A; Supplemental Tables 1 and 4). They are also significantly smaller than their wild-type littermates (Supplemental Table 2) and show increased renal Ca2+ excretion (Figure 1B). Klotho−/− mice have a lower urinary pH (Figure 1C), a reduced urine output, and more concentrated urine, although their daily water intake (when corrected for weight) is greater (Supplemental Table 2). The decrease in urinary volume remained significant even when urine output was corrected for the weight of the mice. To rule out the possibility that a metabolic acidosis was driving the aciduria, we performed venous blood gas analysis. The results indicated that klotho−/− mice had a respiratory acidosis (decreased plasma pH, increased CO2, and increased bicarbonate; Supplemental Table 3).
Intestinal Hyperabsorption Contributes to Elevated Serum Ca2+ Levels in Klotho−/− Mice
We proceeded to evaluate the molecular mechanisms mediating active Ca2+ transport from the intestine. First, quantitative real-time PCR (qPCR) was performed on duodenal samples from klotho−/− and wild-type mice for TRPV6, calbindin-D9K, and plasma membrane Ca2+-ATPase (PMCA1b). This showed an increase in the mRNA level of both TRPV6 and calbindin-D9K in klotho−/− mice and no alteration in PMCA1b expression (Figure 2, A–C). These results are consistent with the elevated 1,25(OH)2D3 levels present in klotho−/− mice (Supplemental Table 1). That the altered mRNA expression translated into increased protein expression was shown by immunoblotting for calbindin-D9K (Figure 2, D and E). Importantly, the functional consequences of these observations were determined by measuring intestinal Ca2+ uptake. This showed that klotho−/− mice absorb 45Ca2+ at a faster rate than their wild-type littermates (Figure 2F).
Opposite Expression Levels of Renal Ca2+ Transport Proteins in Klotho−/− Mice
The effect of increased intestinal Ca2+ uptake and 1,25(OH)2D3 levels on the expression of renal Ca2+ handling proteins was assessed. First, using qPCR, the renal expression of TRPV5, calbindin-D28K, NCX1, and PMCA1b was evaluated. The expression of TRPV5 mRNA was found to be significantly elevated (Figure 3A). In contrast, the expression of both NCX1 and calbindin-D28K was decreased (Figure 3, B and C), whereas PMCA1b expression was unaltered (Figure 3D). We proceeded to substantiate these findings; first the protein expression of calbindin-D28K was measured and determined to be downregulated via semiquantitative immunoblotting (Figure 3, E and F). Then, the level of TRPV5 protein expression was determined by quantification of fluorescence from kidney sections that had been immunolabeled with an antibody against TRPV5. This was also in agreement with the findings of the mRNA analysis; TRPV5 protein expression was upregulated in the klotho−/− mice relative to their wild-type littermates (Figure 3, G and H).
To exclude the possibility of renal 1,25(OH)2D3 resistance, we measured calbindin-D9K, vitamin D receptor (VDR), and 25-hydroxyvitamin D-1-α-hydroxylase (1αOHase) mRNA expression in the kidney. Calbindin-D9K expression was appropriately increased in the klotho−/− mice relative to their wild-type littermates on the control diet (Supplemental Figure 3A). The protein expression of calbindin-D9K was upregulated in klotho−/− mice as well (Supplemental Figure 3D). VDR mRNA and protein expression was unaltered (Supplemental Figure 3, B and E), whereas 1αOHase was increased at the mRNA level in klotho−/− mice (Supplemental Figure 3C).
Klotho−/− Mice Develop Ca2+-P(i) Precipitates in the DCT/CNT
The presence of concentrated urine and hypercalciuria prompted us to look at the expression of aquaporin-2. Semiquantitative immunoblot analysis of aquaporin-2 expression from kidney lysate of wild-type and klotho−/− mice showed an increased expression in klotho−/− mice (Figure 3, I and J), despite an elevated urinary Ca2+ excretion (Figure 1B). The functional consequence of hypercalciuria in klotho−/− mice was therefore studied.
Von Kossa staining identified Ca2+ precipitates throughout the cortex of the klotho−/− mice (Figure 4, A and B). Energy-dispersive x-ray microanalysis (EDX) measurements were used and showed that the precipitates consisted of Ca2+-P(i) (Figure 4, E and F). Higher-resolution imaging was used to identify their location. Both electron microscopy and light microscopy of Toluidine blue–stained sections identified the presence of Ca2+-P(i) precipitates decorating what appeared to be DCT/CNT (Figure 4, C and D). To confirm that the precipitates were predominately confined to the DCT/CNT, we performed von Kossa staining on knockout kidney sections and identified the DCT/CNT region by fluorescently labeling with calbindin-D28K (Figure 4, G–I). This confirmed that many of the segments expressing calbindin-D28K also contained precipitates (Figure 4, G-I; Supplemental Figure 1, A–C). To exclude the possibility that the precipitates were predominantly present in proximal tubules (PTs), after von Kossa staining, PTs were identified by immunofluorescent labeling with the breast cancer resistance protein.14 This confirmed that the majority of Ca2+-P(i) precipitates were not in the PT (Supplemental Figure 1, D–F). Renal pelvis dilation was not observed in klotho−/− mice, implying the absence of hydronephrosis or precipitates in the ureter.
Renal Ca2+ Wasting Is a Primary Defect in Klotho−/− Mice
To ascertain whether the renal Ca2+ leak was primary or secondary to an increased serum Ca2+ or 1,25(OH)2D3 level, these parameters were normalized in the klotho−/− mice. This was accomplished by feeding the animals a low Ca2+, P(i), and vitamin D (<0.13 μg/kg calciferol) diet (LVD) (Supplemental Tables 4 and 5). This diet increased the weight of the klotho−/− mice to that of the wild-type animals (Supplemental Table 5). LVD also brought the serum level of Ca2+ and 1,25(OH)2D3 back into the normal range (Figure 5, A and B). Consistent with the hypothesis that klotho−/− mice have a primary renal Ca2+ leak, the normalization of these parameters failed to revert renal Ca2+ excretion to that of the wild-type animal (Figure 5C). Furthermore, the expression of TRPV5 remained elevated in klotho−/− mice, despite a greatly reduced 1,25(OH)2D3 level, whereas calbindin-D28K expression was consistently lower (Figure 5, D and E). However, intestinal and renal calbindin-D9K expression returned to the level of the wild-type mice (Figure 5F; Supplemental Figure 3, A and D). Interestingly, renal cortical Ca2+ precipitates remained in some of the klotho−/− mice, albeit to a reduced extent, despite normalization of their serum Ca2+ and 1,25(OH)2D3 levels (Supplemental Figure 2).
To assess the consequences on bone, a detailed structural analysis of femurs was performed. Klotho−/− mice have reduced bone mass compared with wild-type littermates (Figure 5G). Both trabecular and cortical thickness are significantly decreased, leading to lower trabecular and cortical bone volume and a severely reduced trabecular bone fraction (Figure 5G; Supplemental Table 6). Trabecular number is also significantly decreased in klotho−/− mice (Supplemental Table 6). On LVD, the bone phenotype of klotho−/− mice resembles that of wild-type mice fed the LVD diet (Figure 5G). This is corroborated by complete restoration of all bone structural parameters to wild-type values (Supplemental Table 6). In addition, LVD seems to increase femur length, perimeter, and femoral head volume in both wild-type and klotho−/− mice (Supplemental Table 6).
Discussion
This study clearly showed that increased renal Ca2+ excretion in klotho−/− mice is a primary disturbance. It is neither the result of increased serum Ca2+ levels nor elevated 1,25(OH)2D3 levels. Instead, our findings are consistent with a failure of klotho to maintain TRPV5 activity in the DCT/CNT (presumably through failing to retain it in the apical plasma membrane). Klotho−/− mice show hypercalcemia, elevated 1,25(OH)2D3 levels, hyperabsorption of Ca2+ from their intestine, and severe osteopenia. Renal Ca2+ excretion is increased, despite elevated TRPV5 expression. However, the renal expression of calbindin-D28K and NCX1 parallels that of the TRPV5 knockout mice; in both cases, they are reduced,12,15 implying a failure for klotho−/− mice to reabsorb Ca2+ from the DCT/CNT via TRPV5. To exclude the possibility that renal Ca2+ wasting was secondary to increased serum Ca2+ or 1,25(OH)2D3 levels, we normalized these parameters in the klotho−/− mice. This prevented the development of osteopenia and the increase in intestinal calbindin-D9K expression. However, despite reduced serum Ca2+ and 1,25(OH)2D3 levels, klotho−/− mice had persistently elevated renal Ca2+ excretion. Thus, renal Ca2+ wasting is a primary defect in klotho−/− mice. This in turn may in fact drive increased 1,25(OH)2D3 synthesis, intestinal Ca2+ hyperabsorption, resorption from bone, and hypercalcemia.16 Regardless, a primary renal Ca2+ leak contributes to nephrocalcinosis.
Central to the aging phenotype observed in klotho−/− mice is Ca2+ precipitation throughout many organ systems, not the least of which is the kidney as shown recently by Ohnishi et al.8 This has been largely attributed to the formation of ectopic calcifications.6 By examining the renal precipitations more closely, we were able to identify the presence of discrete calcifications confined to distinct tubular segments, suggesting a tubular pathology. The specific composition of the precipitates was delineated and found to be Ca2+-P(i), a finding consistent with the increased renal Ca2+ and P(i) excretion observed in klotho−/− mice (Supplemental Table 2).4,17 In fact, the dramatic increase in the urinary composition of these ions likely resulted in their precipitation. The exact location of the Ca2+-P(i) precipitates was further studied, first with light and electron microscopy and then more specifically by immunofluorescence microscopy. Using the combination of von Kossa staining to detect Ca2+ deposits and nephron-specific immunofluorescence microscopy, we were able to localize the majority of precipitates to the DCT/CNT. This is the nephron segment where TRPV518 and klotho17 are expressed. TRPV5 activity is required to absorb Ca2+ back into the blood from the DCT/CNT lumen.12 It appears that a failure to do so, unless compensated by regulatory mechanisms, results in Ca2+-P(i) precipitation. Although we observed cortical tubular precipitations or nephrocalcinosis, our results imply that within the ureter obstructions are not present nor do these mice suffer from hydronephrosis. Cases of obstructive nephropathy or hydronephrosis in either klotho−/− or FGF23−/− mice have not been reported in the literature. The acidification of urine provides a protective mechanism against Ca2+-P(i) precipitation.19 Klotho−/− mice have significantly acidified urine compared with their wild-type littermates. Their urinary acidification is not caused by a metabolic acidosis. Instead, it is likely a response to hypercalciuria and an attempt to prevent nephrocalcinosis. Thus, this finding provides further evidence of a renal Ca2+ leak. Another protective mechanism against nephrocalcinosis is urinary dilution. Increased delivery of Ca2+ to the DCT/CNT should dilute the urine by downregulating aquaporin-2 expression.20 However, klotho−/− mice have concentrated urine compared with wild-type mice. This contributes to the formation of Ca2+-P(i) precipitates and augments our understanding of this process. The reason for this apparent discrepancy is a greater need to protect intravascular volume than prevent stone formation. Klotho−/− mice would tend toward a reduced intravascular volume because they clearly have increased insensible losses. This latter phenomenon is the combined result of increased surface area to weight ratio and skin and lung disease. The presence of lung disease is evidenced by a respiratory acidosis in klotho−/− mice and the literature (Supplemental Table 3).21,22 Regardless, clearly both acidification and dilution of urine are needed to prevent salt precipitations in the presence of increased Ca2+ excretion. A concentrated urine in the presence of hypercalciuria contributes to the formation of renal Ca2+-P(i) precipitates in the klotho−/− mice.
Increased TRPV5 and decreased calbindin-D28K and NCX1 expression is seemingly paradoxical. To exclude the possibility that they represent renal 1,25(OH)2D3 resistance, we measured calbindin-D9K and VDR expression (Supplemental Figure 3). Calbindin-D9K expression was appropriately increased in the presence of increased 1,25(OH)2D3 and reduced to wild-type levels by dietary restriction. Moreover, decreased VDR expression in klotho−/− mice cannot explain this observation. The observed upregulation of 1αOHase in klotho−/− mice is in agreement with the literature.6,8 1αOHase mRNA expression is also enhanced in FGF23−/− mice,23 and administration of FGF23 to wildtype mice reduces 1αOHase gene levels.24 In vitro experiments have shown that the FGF23 signaling pathway is mediated via extracellular signal–regulated kinase 1/2.24 These findings are consistent with klotho, in concert with FGF23, participating in an inhibitory feedback loop that results in the suppression of 1,25(OH)2D3 synthesis, as has also been discussed by others.6 Regardless, rather than supporting the presence of renal 1,25(OH)2D3 resistance, these findings are compatible with a defect in active transcellular Ca2+ absorption from the DCT/CNT through TRPV5.12,15 The rate of Ca2+ influx determines the level of calbindin-D28K and NCX1 expression12,15,25; consequently, the low expression levels of these proteins suggest impaired Ca2+ influx through TRPV5. Although TRPV5 expression is increased, it is probably functionally insignificant, because TRPV5 is likely not retained in the plasma membrane because of the absence of klotho.10,11 This is consistent with the observation that the application of klotho to cells expressing TRPV5 greatly increases cell surface expression and activity of the channel.10,11 Specifically, in vitro, klotho, by cleaving the terminal sialic acid residue on the N-linked glycosylation site of TRPV5, exposes a glycosylation sequence that permits galectin-1 to retain TRPV5 in the apical membrane.11 Moreover, microperfusion studies of isolated DCT/CNT from klotho−/− mice fail to show increased Ca2+ influx in the presence of parathyroid hormone,9 a process mediated by TRPV5. Together these results provide strong evidence of a primary defect in DCT/CNT TRPV5 activation in klotho−/− mice, both in vitro and now in vivo. Our findings support a central role for klotho in Ca2+ homeostasis by preventing renal Ca2+ loss and the commonly associated problems nephrolithiasis and osteopenia. Both of these clinical problems occur more frequently with advanced age, as does the incidence of hypercalciuria. Thus, our results provide further molecular details of the contribution of klotho to the problems associated with advanced age.
To exclude the possibility that the increased Ca2+ excretion observed in klotho−/− mice was caused by a secondary effect of hypervitaminosis D or hypercalcemia, we normalized both these parameters. This experiment clearly showed that the fractional excretion of Ca2+ in klotho−/− mice remains elevated, even in the absence of increased serum 1,25(OH)2D3 or Ca2+ levels. In contrast, the elevated levels of calbindin-D9K were normalized by this perturbation, suggesting that elevated 1,25(OH)2D3 levels were driving their expression. This result is similar to that observed in bone. Normalization of serum 1,25(OH)2D3 levels in klotho−/− mice prevented osteopenia, suggesting that this abnormality may also be secondary to the increased 1,25(OH)2D3 level. Although renal Ca2+ wasting will cause increased serum 1,25(OH)2D3 levels, we cannot exclude the role of klotho in FGF23 signaling from contributing to this abnormality in klotho−/− mice. Indeed both these mechanisms likely contribute to the particularly elevated levels of serum 1,25(OH)2D3 and Ca2+ observed in these animals.
Our results clearly showed a reduction in cortical volume, trabecular density, and trabeculae number in klotho−/− mice on a control diet (Supplemental Table 6). Consequently, the thinner trabecular bone structures become apparent in the 3D reconstruction (Figure 5G). Our observations differ from the previously reported studies26–31 in that we found decreased trabecular thickness, volume, and number per area; however, our cortical analyses are consistent with these reports. The trabecular differences may be because of the age of the mice we analyzed (7 to 8 wk old versus 4 to 5 wk in some studies28–30). Perhaps in these weeks, accelerated aging occurs, which could explain the observed discrepancy. Another variation between some of those reports and ours is the long bone studied. We performed detailed analysis on femurs, whereas previous authors have focused more on the tibia.26,30 The genetic background of the klotho−/− mice also differs between some of these reports. In our experiments, klotho−/− mice with a C57Bl6 background were used, whereas Yamashita et al.31 performed studies in klotho−/− mice generated from a C3H strain. Furthermore, as with the other studies, ours was completed on young mice with immature skeletons; as such, these results may not apply to an aging skeleton.
In summary, we provide in vivo data consistent with decreased TRPV5 activity in klotho−/− mice. This is a primary consequence of the absence of klotho and not secondary to elevated serum Ca2+ and 1,25[OH)]2D3 levels. In fact, these latter findings are likely a direct consequence of this abnormality, because the expression of Ca2+-transporting proteins was normalized and osteopenia was prevented by reducing the serum concentration of 1,25(OH)2D3. In contrast, this fails to return the fractional excretion of Ca2+ to that of the wild-type animals, providing direct evidence for a primary renal Ca2+ leak. This likely drives the hypervitaminosis D and hypercalciuria and contributes to the formation of nephrocalcinosis in DCT/CNT of klotho−/− mice. We therefore provided evidence that klotho activates TRPV5 in vivo, thereby explaining its central role in Ca2+ homeostasis.
Concise Methods
Generation and Characterization of Klotho−/− Mice
Heterozygous klotho−/− mice were purchased from Mutant Mouse Regionale Resource Centers (ID: 011732-UCD); the details of their generation are provided elsewhere.32 These were bred to C57Bl/6 wild-type animals, and the heterozygous offspring were crossed to produce klotho−/− animals. Standard pelleted chow (0.25% [wt/vol] Na, 1.1% [wt/vol] Ca, 0.2% [wt/vol] Mg, 0.7% [wt/vol] P(i), and 0.9% [wt/vol] K) and drinking water were available ad libitum. Klotho−/− and wild-type animals were housed in metabolic cages for 24 h at a time (n = 10 of each). All experiments were performed in compliance with the animal ethics board of the Radboud University Nijmegen.
Low Ca2+, P(i), and 1,25(OH)2D3 Diet
After crossing heterozygous pairs, produced as described above, pregnant females were separated into individual cages and allocated to either the control diet (CD) or LVD. The content of the control, synthetic diet consisted of [0.19% [wt/vol] Na, 0.9% [wt/vol] Ca, 0.21% [wt/vol] Mg, 0.63% [wt/vol] P, and 0.97% [wt/vol] K, and 1500 IU 1,25(OH)2D3], and the LVD contained (0.19% [wt/vol] Na, 0.34% [wt/vol] Ca, 0.21% [wt/vol] Mg, 0.22% [wt/vol] P, 0.97% [wt/vol] K, and <5 IU Vitamin D). Lactating mothers continued to receive the allocated diet, and the pups, on weaning, were fed the appropriate diet. Between 7 and 8 wk of age, the klotho−/− mice and wild-type animals were housed in metabolic cages for 24 h, after which blood was collected, mice were killed, and tissue was sampled.
Characterization of Ca2+ Homeostasis
Serum and urine Ca2+ concentration was determined using a colorimetric assay kit as described previously.33 A flame spectrophotometer (FCM 6343; Eppendorf, Hamburg, Germany) was used to measure serum and urine Na+ concentrations and urine K+ concentrations. Serum and urine P(i) and creatinine concentrations and venous blood gases were determined using a Hitachi autoanalyzer (Hitachi, Laval, Quebec, Canada). Serum and urine osmolarity was obtained using a Halbmikro-Osmometer K-7400 (Knauer, Berlin, Germany). The in vivo 45Ca2+ absorption assay was performed as described elsewhere.34 qPCR for TRPV5, TRPV6, calbindin-D9K, calbindin-D28K, NCX1, PMCA1b, VDR, and 1αOHase was completed essentially as described previously.35–37 Immunohistochemistry and its quantification for TRPV5 followed the procedure detailed elsewhere.38 Semiquantitative immunoblotting for calbindin-D28K, calbindin-D9K, and aquaporin-2 has been described previously39,40 Polyclonal anti-VDR antibody (Santa Cruz Biotechnology, Santa Cruz, CA) was used at a dilution of 1:200. Von Kossa staining was performed to visualize Ca2+-containing precipitates.
Electron Microscopy
Renal tubular Ca2+ precipitations were analyzed by transmission electron microscopy. Kidney samples were fixed in 2.5% (wt/vol) glutaraldehyde dissolved in 0.1 M cacodylate buffer, pH 7.4, at room temperature for 2 h after dissection. Samples were subsequently washed three times with 0.1 M sodium cacodylate buffer and postfixed with 1% (wt/vol) osmium tetroxide in 0.1 M sodium cacodylate buffer at room temperature for 1 h. Samples were dehydrated and processed for embedding in Epon resin. Polymerization was performed in a 60°C oven. For morphology studies, sections were cut using a diamond knife and mounted on copper grids (100 mesh). Sections were stained with uranyl acetate and lead citrate and examined using a Jeol 1200 EX II. For EDX measurements, section thickness was approximately 200 nm, and postfixation was omitted, not contrasted, and subsequently examined using a Jeol 1200/STEM in combination with a Thermo Noran microanalysis SIX system (Thermo Fisher Scientific, Waltham, MA). Accelerated voltage of 60 keV was used for x-ray microanalysis. X-ray spectra and maps for Ca2+ and P(i) distribution were acquired.
Bone Structural Analysis
After fixation in 10% (wt/vol) formalin and measuring their lengths, femurs from both wildtype and klotho−/− mice on control diet (CD-WT and CD-KO, respectively; n = 4) and wildtype and klotho−/− mice on LVD (LVD-WT and LVD-KO, respectively; n = 4) were studied in detail by scanning them in an in vivo microcomputed tomography scanner (Skyscan 1076; Skyscan, Aartselaar, Belgium). Scans were processed, and three-dimensional morphometric analyses of the bones were performed, using free software of the 3D-calculator project (www.skyscan.be/products/downloads.htm) as described earlier.12 All parameters were expressed according to the bone histomorphometry nomenclature.41 The region of interest was confined to the proximal half of the femur and contained both trabecular (scan area, 0 to 4.1 mm; indicated in Figure 5G) and cortical (scan area, 7.2 to 8.1 mm) bone structures, enabling accurate analysis of a number of parameters in both compartments. Using several software packages, three-dimensional representations were made from femurs of each experimental group.
Statistical Analysis
Data are expressed as mean ± SEM. Statistical comparisons were analyzed by one-way ANOVA with a Bonferroni correction for multiple comparison. A P < 0.05 was considered statistically significant. All analyses were performed using the SPSS Statistical Package software (Power PC version 4.51; Abacus Concepts).
Further details of the materials and methods can be found online.
Disclosures
None.
Acknowledgments
R.T.A. is supported by a phase I Clinician Scientist award from the Canadian Institute of Health Research and a KRESCENT postdoctoral award from the Kidney Foundation of Canada. This work was supported by The Netherlands Organization for Scientific Research (NWO-ALW 814.02.001, NWO-CW 700.55.302, ZonMw 9120.6110), EURYI award from the European Science Foundation, and the Dutch Kidney foundation (C03.6017, C06.2170). We thank Henk Arnts and Bianca Lemmers-Van de Weem (CDL, UMC Nijmegen) for their excellent technical assistance with the animal experiments and Sander Botter of the Erasmus MC, Rotterdam, The Netherlands, for his technical assistance concerning the microcomputed tomography procedures.
Footnotes
Published online ahead of print. Publication date available at www.jasn.org.
Supplemental information for this article is available online at http://www.jasn.org/.
References
- 1.Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI: Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390: 45–51, 1997 [DOI] [PubMed] [Google Scholar]
- 2.Kuro-o M: Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism. Curr Opin Nephrol Hypertens, 15: 437–441, 2006 [DOI] [PubMed] [Google Scholar]
- 3.Torres PU, Prie D, Molina-Bletry V, Beck L, Silve C, Friedlander G: Klotho: An antiaging protein involved in mineral and vitamin D metabolism. Kidney Int, 71: 730–737, 2007 [DOI] [PubMed] [Google Scholar]
- 4.Yahata K, Mori K, Mukoyama M, Sugawara A, Suganami T, Makino H, Nagae T, Fujinaga Y, Nabeshima Y, Nakao K: Regulation of stanniocalcin 1 and 2 expression in the kidney by klotho gene. Biochem Biophys Res Commun 310: 128–134, 2003 [DOI] [PubMed] [Google Scholar]
- 5.Segawa H, Yamanaka S, Ohno Y, Onitsuka A, Shiozawa K, Aranami F, Furutani J, Tomoe Y, Ito M, Kuwahata M, Imura A, Nabeshima Y, Miyamoto K: Correlation between hyperphosphatemia and type II Na-Pi cotransporter activity in klotho mice. Am J Physiol Renal Physiol 292: F769–F779, 2007 [DOI] [PubMed] [Google Scholar]
- 6.Tsujikawa H, Kurotaki Y, Fujimori T, Fukuda K, Nabeshima Y: Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol Endocrinol 17: 2393–2403, 2003 [DOI] [PubMed] [Google Scholar]
- 7.Yoshida T, Fujimori T, Nabeshima Y: Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1alpha-hydroxylase gene. Endocrinology 143: 683–689, 2002 [DOI] [PubMed] [Google Scholar]
- 8.Ohnishi M, Nakatani T, Lanske B, Razzaque MS: Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase. Kidney Int 75: 1166–1172, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Tsuruoka S, Nishiki K, Ioka T, Ando H, Saito Y, Kurabayashi M, Nagai R, Fujimura A: Defect in parathyroid-hormone-induced luminal calcium absorption in connecting tubules of Klotho mice. Nephrol Dial Transplant 21: 2762–2767, 2006 [DOI] [PubMed] [Google Scholar]
- 10.Chang Q, Hoefs S, van der Kemp AW, Topala CN, Bindels RJ, Hoenderop JG: The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science 310: 490–493, 2005 [DOI] [PubMed] [Google Scholar]
- 11.Cha SK, Ortega B, Kurosu H, Rosenblatt KP, Kuro-o M, Huang CL: Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1. Proc Natl Acad Sci U S A 105: 9805–9810, 2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Hoenderop JG, van Leeuwen JP, van der Eerden BC, Kersten FF, van der Kemp AW, Merillat AM, Waarsing JH, Rossier BC, Vallon V, Hummler E, Bindels RJ: Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5. J Clin Invest 112: 1906–1914, 2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Mensenkamp AR, Hoenderop JG, Bindels RJ: TRPV5, the gateway to Ca2+ homeostasis. Handb Exp Pharmacol 179: 207–220, 2007 [DOI] [PubMed] [Google Scholar]
- 14.Huls M, Brown CD, Windass AS, Sayer R, van den Heuvel JJ, Heemskerk S, Russel FG, Masereeuw R: The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane. Kidney Int 73: 220–225, 2008 [DOI] [PubMed] [Google Scholar]
- 15.Renkema KY, Nijenhuis T, van der Eerden BC, van der Kemp AW, Weinans H, van Leeuwen JP, Bindels RJ, Hoenderop JG: Hypervitaminosis D mediates compensatory Ca2+ hyperabsorption in TRPV5 knockout mice. J Am Soc Nephrol 16: 3188–3195, 2005 [DOI] [PubMed] [Google Scholar]
- 16.Selby PL, Davies M, Marks JS, Mawer EB: Vitamin D intoxication causes hypercalcaemia by increased bone resorption which responds to pamidronate. Clin Endocrinol (Oxf) 43: 531–536, 1995 [DOI] [PubMed] [Google Scholar]
- 17.Li SA, Watanabe M, Yamada H, Nagai A, Kinuta M, Takei K: Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice. Cell Struct Funct 29: 91–99, 2004 [DOI] [PubMed] [Google Scholar]
- 18.Loffing J, Loffing-Cueni D, Valderrabano V, Klausli L, Hebert SC, Rossier BC, Hoenderop JG, Bindels RJ, Kaissling B: Distribution of transcellular calcium and sodium transport pathways along mouse distal nephron. Am J Physiol Renal Physiol 281: F1021–F1027, 2001 [DOI] [PubMed] [Google Scholar]
- 19.Wagner CA: When proton pumps go sour: Urinary acidification and kidney stones. Kidney Int 73: 1103–1105, 2008 [DOI] [PubMed] [Google Scholar]
- 20.Earm JH, Christensen BM, Frokiaer J, Marples D, Han JS, Knepper MA, Nielsen S: Decreased aquaporin-2 expression and apical plasma membrane delivery in kidney collecting ducts of polyuric hypercalcemic rats. J Am Soc Nephrol 9: 2181–2193, 1998 [DOI] [PubMed] [Google Scholar]
- 21.Sato A, Hirai T, Imura A, Kita N, Iwano A, Muro S, Nabeshima Y, Suki B, Mishima M: Morphological mechanism of the development of pulmonary emphysema in klotho mice. Proc Natl Acad Sci U S A 104: 2361–2365, 2007 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Suga T, Kurabayashi M, Sando Y, Ohyama Y, Maeno T, Maeno Y, Aizawa H, Matsumura Y, Kuwaki T, Kuro OM, Nabeshima Y, Nagai R: Disruption of the klotho gene causes pulmonary emphysema in mice. Defect in maintenance of pulmonary integrity during postnatal life. Am J Respir Cell Mol Biol 22: 26–33, 2000 [DOI] [PubMed] [Google Scholar]
- 23.Nakatani T, Sarraj B, Ohnishi M, Densmore MJ, Taguchi T, Goetz R, Mohammadi M, Lanske B, Razzaque MS: In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis. Faseb J 23: 433–441, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Perwad F, Zhang MY, Tenenhouse HS, Portale AA: Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro. Am J Physiol Renal Physiol 293: F1577–F1583, 2007 [DOI] [PubMed] [Google Scholar]
- 25.Nijenhuis T, Vallon V, van der Kemp AW, Loffing J, Hoenderop JG, Bindels RJ: Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest 115: 1651–1658, 2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Kawaguchi H, Manabe N, Miyaura C, Chikuda H, Nakamura K, Kuro-o M: Independent impairment of osteoblast and osteoclast differentiation in klotho mouse exhibiting low-turnover osteopenia. J Clin Invest 104: 229–237, 1999 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Kawaguchi H, Manabe N, Chikuda H, Nakamura K, Kuroo M: Cellular and molecular mechanism of low-turnover osteopenia in the klotho-deficient mouse. Cell Mol Life Sci 57: 731–737, 2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Suzuki H, Amizuka N, Oda K, Noda M, Ohshima H, Maeda T: Histological and elemental analyses of impaired bone mineralization in klotho-deficient mice. J Anat 212: 275–285, 2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Yamashita T, Nabeshima Y, Noda M: High-resolution micro-computed tomography analyses of the abnormal trabecular bone structures in klotho gene mutant mice. J Endocrinol 164: 239–245, 2000 [DOI] [PubMed] [Google Scholar]
- 30.Kashimada K, Yamashita T, Tsuji K, Nifuji A, Mizutani S, Nabeshima Y, Noda M: Defects in growth and bone metabolism in klotho mutant mice are resistant to GH treatment. J Endocrinol 174: 403–410, 2002 [DOI] [PubMed] [Google Scholar]
- 31.Yamashita T, Okada S, Higashio K, Nabeshima Y, Noda M: Double mutations in klotho and osteoprotegerin gene loci rescued osteopetrotic phenotype. Endocrinology 143: 4711–4717, 2002 [DOI] [PubMed] [Google Scholar]
- 32.Takeshita K, Fujimori T, Kurotaki Y, Honjo H, Tsujikawa H, Yasui K, Lee JK, Kamiya K, Kitaichi K, Yamamoto K, Ito M, Kondo T, Iino S, Inden Y, Hirai M, Murohara T, Kodama I, Nabeshima Y: Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression. Circulation 109: 1776–1782, 2004 [DOI] [PubMed] [Google Scholar]
- 33.Bindels RJ, Hartog A, Abrahamse SL, Van Os CH: Effects of pH on apical calcium entry and active calcium transport in rabbit cortical collecting system. Am J Physiol 266: F620–F627, 1994 [DOI] [PubMed] [Google Scholar]
- 34.Van Cromphaut SJ, Dewerchin M, Hoenderop JG, Stockmans I, Van Herck E, Kato S, Bindels RJ, Collen D, Carmeliet P, Bouillon R, Carmeliet G: Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proc Natl Acad Sci U S A 98: 13324–13329, 2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Nijenhuis T, Hoenderop JG, Loffing J, van der Kemp AW, van Os CH, Bindels RJ: Thiazide-induced hypocalciuria is accompanied by a decreased expression of Ca2+ transport proteins in kidney. Kidney Int 64: 555–564, 2003 [DOI] [PubMed] [Google Scholar]
- 36.van Abel M, Huybers S, Hoenderop JG, van der Kemp AW, van Leeuwen JP, Bindels RJ: Age-dependent alterations in Ca2+ homeostasis: role of TRPV5 and TRPV6. Am J Physiol Renal Physiol 291: F1177–F1183, 2006 [DOI] [PubMed] [Google Scholar]
- 37.van Abel M, Hoenderop JG, van der Kemp AW, van Leeuwen JP, Bindels RJ: Regulation of the epithelial Ca2+ channels in small intestine as studied by quantitative mRNA detection. Am J Physiol Gastrointest Liver Physiol 285: G78–G85, 2003 [DOI] [PubMed] [Google Scholar]
- 38.Hoenderop JG, Hartog A, Stuiver M, Doucet A, Willems PH, Bindels RJ: Localization of the epithelial Ca2+ channel in rabbit kidney and intestine. J Am Soc Nephrol 11: 1171–1178, 2000 [DOI] [PubMed] [Google Scholar]
- 39.Huybers S, Apostolaki M, van der Eerden BC, Kollias G, Naber TH, Bindels RJ, Hoenderop JG: Murine TNF(DeltaARE) Crohn's disease model displays diminished expression of intestinal Ca2+ transporters. Inflamm Bowel Dis 14: 803–811, 2008 [DOI] [PubMed] [Google Scholar]
- 40.Kamsteeg EJ, Heijnen I, van Os CH, Deen PM: The subcellular localization of an aquaporin-2 tetramer depends on the stoichiometry of phosphorylated and nonphosphorylated monomers. J Cell Biol 151: 919–930, 2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Parfitt AM, Simon LS, Villanueva AR, Krane SM: Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with Iliac bone formation rates and comparison with total alkaline phosphatase. J Bone Miner Res 2: 427–436, 1987 [DOI] [PubMed] [Google Scholar]